
Chari A, Larson S, Holkova B, et al. Phase 1 trial of ibrutinib
Advertisement
Articles by Chari A, Larson S, Holkova B, et al. Phase 1 trial of ibrutinib

Advertisement
Latest Updated Articles
Study Summary: Ibrutinib Plus Carfilzomib for Relapsed or Relapsed/Refractory Multiple MyelomaPublished: October 18th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA to Accept Deidentified Real-World Evidence for Select Medical Device Applications
2
ACA Subsidy Expiration Raises Concerns for Behavioral Health Access and ED Strain
3
HIV in 2025 Defined by Challenges Throughout the Year, Despite Some Advances
4
FDA Approves Intranasal Etripamil for Type of Arrhythmia
5



